Experimental studies using OMV in a new platform of SARS-CoV-2 vaccines

Adjuvanted SARS-CoV-2 spike protein elicits neutralizing antibodies and CD4 T cell responses after a single immunization in mice

(2021) Katharina Wørzner et al.   EBioMedicine

The challenge of avidity determination in SARS‐CoV‐2 serology

(2021) Georg Bauer et al.   JOURNAL OF MEDICAL VIROLOGY

Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia

(2021) Denis Y Logunov et al.   LANCET

Avidity assay to test functionality of anti-SARS-Cov-2 antibodies

(2021) Emanuelle Baldo Gaspar et al.   VACCINE

Understanding of COVID‐19 based on current evidence

(2020) Pengfei Sun et al.   JOURNAL OF MEDICAL VIROLOGY

Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses

(2020) Michael Letko et al.   Nature Microbiology

Elevated plasma level of selective cytokines in COVID-19 patients reflect viral load and lung injury

(2020) Yingxia Liu et al.   National Science Review

Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19

(2020) Yuan Huang et al.   ACTA PHARMACOLOGICA SINICA

OMV Vaccines and the Role of TLR Agonists in Immune Response

(2020) Francesca Mancini et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Could IL-17 represent a new therapeutic target for the treatment and/or management of COVID-19-related respiratory syndrome?

(2020) Gian Marco Casillo et al.   PHARMACOLOGICAL RESEARCH

Molecular structure analyses suggest strategies to therapeutically target SARS-CoV-2

(2020) Yi Zhang et al.   Nature Communications

The socio-economic implications of the coronavirus pandemic (COVID-19): A review

(2020) Maria Nicola et al.   International Journal of Surgery

Immune responses of meningococcal B outer membrane vesicles in middle-aged mice

(2020) Gabriela Trzewikoswki de Lima et al.   Pathogens and Disease

Mechanisms of SARS-CoV-2 transmission and pathogenesis

(2020) Andrew G. Harrison et al.   TRENDS IN IMMUNOLOGY

Blocking of the High-Affinity Interaction-Synapse Between SARS-CoV-2 Spike and Human ACE2 Proteins Likely Requires Multiple High-Affinity Antibodies: An Immune Perspective

(2020) Indu Khatri et al.   Frontiers in Immunology

GMMA Is a Versatile Platform to Design Effective Multivalent Combination Vaccines

(2020) Francesca Micoli et al.   Vaccines

Cytokine profile and disease severity in patients with COVID-19

(2020) Ali Ghazavi et al.   CYTOKINE

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

(2020) Merryn Voysey et al.   LANCET

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

(2020) Fernando P. Polack et al.   NEW ENGLAND JOURNAL OF MEDICINE

IgA dominates the early neutralizing antibody response to SARS-CoV-2

(2020) Delphine Sterlin et al.   Science Translational Medicine

Outer membrane protein complex as a carrier for malaria transmission blocking antigen Pfs230

(2019) Puthupparampil V. Scaria et al.   npj Vaccines

Evaluation of intranasal and subcutaneous route of immunization in neonatal mice using DODAB-BF as adjuvant with outer membrane vesicles of Neisseria meningitis B

(2018) Fernanda Ayane de Oliveira Santos et al.   IMMUNOBIOLOGY

A trivalent Apx-fusion protein delivered by E. coli outer membrane vesicles induce protection against Actinobacillus pleuropneumoniae of serotype 1 and 7 challenge in a murine model

(2018) Kui Xu et al.   PLoS One

Safe Recombinant Outer Membrane Vesicles that Display M2e Elicit Heterologous Influenza Protection

(2017) Hannah C. Watkins et al.   MOLECULAR THERAPY

A single dose and long lasting vaccine against pandemic influenza through the controlled release of a heterospecies tandem M2 sequence embedded within detoxified bacterial outer membrane vesicles

(2017) Hannah C. Watkins et al.   VACCINE

Synergistic Protective Activity of Tumor-Specific Epitopes Engineered in Bacterial Outer Membrane Vesicles

(2017) Alberto Grandi et al.   Frontiers in Oncology

A Multi-Component Meningococcal Serogroup B Vaccine (4CMenB): The Clinical Development Program

(2013) Miguel O’Ryan et al.   DRUGS

Immunization with Escherichia coli Outer Membrane Vesicles Protects Bacteria-Induced Lethality via Th1 and Th17 Cell Responses

(2013) O. Y. Kim et al.   JOURNAL OF IMMUNOLOGY

Evidence based route of administration of vaccines

(2011) Ian F. Cook   Human vaccines & immunotherapeutics

Effectiveness of a vaccination programme for an epidemic of meningococcal B in New Zealand

(2011) Richard Arnold et al.   VACCINE

Adjuvant effect of bacterial outer membrane vesicles with penta-acylated lipopolysaccharide on antigen-specific T cell priming

(2011) Dong Ho Lee et al.   VACCINE

Delivery of foreign antigens by engineered outer membrane vesicle vaccines

(2010) D. J. Chen et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Meningococcal Outer Membrane Vesicle Vaccines Derived from Mutant Strains Engineered To Express Factor H Binding Proteins from Antigenic Variant Groups 1 and 2

(2008) O. Koeberling et al.   Clinical and Vaccine Immunology